Facebook Linkedin Twitter
Inside Precision Medicine Potential Action: SiteOne’s $100M Series C to Advance Non-Opioid Pain Drugs

Vertex Pharmaceuticals

Firing Neurons Hologram
News & Features

Potential Action: SiteOne’s $100M Series C to Advance Non-Opioid Pain Drugs

Jonathan D. Grinstein, PhD
0
DNA blood cell on scientific background
News & Features

Beam Therapeutics Sickle Cell Base Editing Works, Not Cause of Patient Death

Jonathan D. Grinstein, PhD
0
Sickle Cell disease - 3D Illustration of sickled blood cells on a dark background
News & Features

New CMS Payment Model Launched for Sickle Cell Gene Therapy

0
Isolated pancreatic islet
News & Features

Where Are the Cell Therapies for Type 1 Diabetes?

Jonathan D. Grinstein, PhD
0
Cancer cell surrounded by therapeutic antibodies and cytokines among normal cells
News & Features

Vertex and Orum Launch $945M+ Collaboration to Replace Chemotherapy with DAC

0
Doctor Measuring Blood Pressure Of A Young Patient with type 1 diabetes to assess benefits of bromocriptine
News & Features

Islet Cell Therapy Breaks Through: Three Patients Become Insulin Independent in Vertex Type 1 Diabetes Trial

0
Red Blood Cells 3D Image Concept
News & Features

CASGEVY Is Durable in over 100 Patients, Editas’ Reni-cel Shows Clinical Promise

0
woman holding her wrist pain because using smartphone or computer long time. De Quervain's tenosynovitis, Intersection Symptom, Carpal Tunnel Syndrome or Office syndrome concept. To illustrate tendon damage
News & Features

Next-Generation Non-Opioid Pain Relievers Advance

0
An illustration of a CRISPR-Cas9 gene editing protein cutting a DNA helix
News & Features

In Another Win for CRISPR, FDA Approves Casgevy for Beta Thalassemia

0
Scientist pipetting sample into a vial for DNA testing
News & Features

Newcomer Tome Acquires Replace TX in $250M Gene Editing Deal

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine